Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.
about
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisA (relatively) risky business: the link between prostatic radiotherapy and second malignanciesThe Effectiveness of Intensity Modulated Radiation Therapy versus Three-Dimensional Radiation Therapy in Prostate Cancer: A Meta-Analysis of the LiteraturesIncidence of second malignancies for prostate cancerCurrent knowledge and future research directions in treatment-related second primary malignancies.Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.The Prognostic Value of Previous Irradiation on Survival of Bladder Cancer PatientsRisk of second cancer following radiotherapy for prostate cancer: a population-based analysis.Recent advances in radiation oncology: intensity-modulated radiotherapy, a clinical perspective.Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.American Cancer Society prostate cancer survivorship care guidelines.Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer.Evaluation of surface and shallow depth dose reductions using a Superflab bolus during conventional and advanced external beam radiotherapy.Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.[Second neoplasms after percutaneous radiotherapy].A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer.Imaging Dose, Cancer Risk and Cost Analysis in Image-guided Radiotherapy of Cancers.Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons
P2860
Q26764960-61C695F2-60EC-4F35-8535-666127EF8C8BQ28388660-F9048004-BAEF-4FD7-9357-EE21C43E5F54Q28552007-DCE9AD50-12AD-4EC8-BA0E-75B8072D05F1Q33927733-9D97CA97-3F66-48FC-8E4C-37206626CD4FQ34604460-1CD81411-8A4B-420C-A6A7-C19AA9160556Q35793117-97939516-BE86-4A50-A481-81E1F7EA7C0EQ35808214-397D0EE5-214D-4095-AF98-731994BA944DQ35976536-F6EB6A09-3B81-4E45-8875-3AC621DCF348Q36895131-03A40595-F049-460D-8046-8134DCE58F44Q37053774-611BD508-8229-43C1-AB52-B6CD84E7BC4BQ37554782-5B3A8ED2-4F51-412A-AD4B-720E2CF89B7DQ38225041-C693A0C9-21E7-4D84-95C5-0638C88B1D22Q38681708-529E3AD4-632D-499B-91F3-E913AEDC9FB8Q41526102-78B665A1-81F8-4E8C-8202-95630142365BQ47109602-D44CB1F4-07CC-47D5-8C07-D14897F708D0Q48073617-5FA29CEF-A82D-417A-B6FA-F51623DB4158Q48187737-FAAC3358-6853-40B7-A666-CDC7F4595DE7Q48503112-73FED7D9-5BCC-42B5-A893-A6E0C047B1E8Q49796174-43367389-7494-4C3C-8ABF-D4CCCC27299BQ51065479-637F4BE2-E187-41BB-864E-2E9F4F75DBE1Q52341978-1E568F66-C954-4429-BBA7-1A070494B060Q55554776-1DF96BF9-FBA7-4C57-B030-E54004FDB861Q58618176-3D44B303-F8E6-40C2-AF95-8297ED33B34A
P2860
Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Second primary cancers after r ...... impact of treatment technique.
@ast
Second primary cancers after r ...... impact of treatment technique.
@en
type
label
Second primary cancers after r ...... impact of treatment technique.
@ast
Second primary cancers after r ...... impact of treatment technique.
@en
prefLabel
Second primary cancers after r ...... impact of treatment technique.
@ast
Second primary cancers after r ...... impact of treatment technique.
@en
P2093
P2860
P31
P1154
2-s2.0-84896389823
P1476
Second primary cancers after r ...... impact of treatment technique.
@en
P2093
Frank-Andre Siebert
Jack Venselaar
Louise Murray
PROBATE group of GEC ESTRO
Peter Hoskin
P2860
P304
P356
10.1016/J.RADONC.2013.12.012
P50
P5008
P5530
P577
2014-01-30T00:00:00Z
2014-02-01T00:00:00Z
P5875
P6179
1030225450